Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Senior City…
This article was written byFollowI focus on long-term investments while incorporating short-term shorts to uncover alpha opportunities. My investment approach…
Receive free Global inflation updatesWe’ll send you a myFT Daily Digest email rounding up the…
By Alla Harmsworth & Robertas Stancikas, CFA We're tactically cautious on developed-market equities with a…
Receive free Toyota Motor Corp updatesWe’ll send you a myFT Daily Digest email rounding up…
By Sammy Suzuki, CFA For over a decade, emerging markets (EMs) have been full of…
Lynn, a Taiwanese stock trader, has never been to Europe. But, in February, she spent…
Commentary With roughly 500 basis points of rate hikes in the rearview mirror, the Federal…
Receive free Indian business & finance updatesWe’ll send you a myFT Daily Digest email rounding…
Amid the AI frenzy and the market pricing in expectations for more accommodative monetary policy…
Receive free Equities updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
AT&T Is Not A Good Business Warren Buffett is known for saying: It's far better…
Receive free Digital World Acquisition Corp updatesWe’ll send you a myFT Daily Digest email rounding…
The second half of 2023 is officially on the way! June ended with a bang…
Emma Dunkley, Siddharth Venkataramakrishnan, Laura Noonan and Jane Croft in LondonThe UK’s financial watchdog has…
Oncolytics Biotech (NASDAQ:ONCY) is a good speculative biotech play to look into. The reason why…
Receive free Russian insurrection updatesWe’ll send you a myFT Daily Digest email rounding up the…
YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!
Sign in to your account
